Matsuda N， Hattori Y. Vascular biology in sepsis: pathophysiologi- cal and therapeutic significance of vascular dysfunction[J]. J Smooth Muscle Res， 2007， 43（4）: 117-137. [2] Jun CD， Shimaoka M， Carman CV， et al . Dimerization and the ef- fectiveness of ICAM-1 in mediating LFA-1-dependent adhesion[J]. Proc Natl Acad Sci USA， 2001， 98（12）: 6830-6835. [3]袁利华，刘承武，姚琦，等.内毒素休克小鼠肝脏血管内皮细胞 特异性结合肽的体内筛选及初步鉴定[J].中国病理生理学杂志， 2008， 35（11）: 1341-1345. [4] Levy MM， Dellinger RP， Townsend SR， et al . The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis[J]. Intensive Care Med， 2010， 36（2）: 222-231. [5] Aird WC. Endothelium in health and disease[J]. Pharmacol Rep， 2008， 60（1）: 139-143. [6] Dauphinee SM， Karsan A. Lipopolysaccharide signaling in endothelial cells[J]. Lab Invest， 2006， 86（1）: 9-22. [7] Pasqualini R， Ruoslahti E. Organ targeting in vivo using phage dis- play peptide libraries[J]. Nature， 1996， 380（6572）: 364-366. [8] Laakkonen P， Zhang L， Ruoslahti E. Peptide targeting of tumor lymph vessels[J]. Ann N Y Acad Sci， 2008， 1131: 37-43. [9] Mueller J， Gaertner FC， Blechert B， et al . Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angio- genesis in vivo[J]. Mol Cancer Res， 2009， 7（7）: 1078-1085. [10] Du B， Han H， Wang Z， et al . targeted drug delivery to hepatocarci- noma in vivo by phage-displayed specific binding peptide[J]. Mol Cancer Res， 2010， 8（2）: 135-144.
